Health

Global Cell Based Assay Market: Market Drivers, Restraints and Opportunities, Market Size & Forecast 2016 to 2022. Becton, Dickinson and Company, GE Healthcare, Cell Signaling Technology, Life Technologies Corporation, Danahar Corporation, Cisbio Bioassays, Merck KGaA and Discoverx Corporation

Press Release

Introduction:

Over the past few years, there has been a growing trend towards more frequent use of cell-based assays for drug discovery, especially since drug development is a billion-dollar business. Cell-based assays refer to any of number of different experiments based on the use of live cells. This is a general definition and can include a variety of assays that measure cell proliferation, toxicity, motility, production of a measurable product, and morphology.

Market Dynamics:

The market has been gaining growth from many factors such as ubiquity of numerous chronic diseases, government support for the research and development activities, and improving healthcare infrastructure in developing countries in Asia Pacific. While, the factors challenging the wellbeing of the global cell based assays market are the curtailment on the usage of reagents and high cost of instruments.

Request For [email protected] https://www.kennethresearch.com/sample-request-10064901

Market Segmentation:
Based on Products:
Consumables
Instruments
Services
Software
Based on End Users:
Biopharmaceutical industries
Contract research organizations
Academic and research institutions
Based on Applications:
Drug discovery
Basic research
ADME studies
Predictive toxicology
Other segments

Regional/Geographical Analysis:
The cell-based assays market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America is expected to dominate the cell-based assays market. The large market share of the region is credited to the growing availability of funds for research and the increase in drug discovery activities in North America. More than one application exists for using cell-based assays, where a large percentage of European-based companies are focussing on ‘biological pathway studies’, ‘assay development’, and ‘drug target identification and screening’.

Buy [email protected] https://www.kennethresearch.com/report-purchase-id-10064901

Opportunities:
Increasing adoption of cell-based consumables by prominent biopharmaceutical companies and growing number of contact research organizations are some of the factors reflecting positively on this market. Currently, pharmaceutical and biotechnology companies serve the maximum demand, which reflects growing adoption of cell-based assays for drug discovery by the end users, especially in the developed countries within North America and Europe.

Key Players:
Becton, Dickinson and Company, GE Healthcare, Cell Signaling Technology, Life Technologies Corporation, Danahar Corporation, Cisbio Bioassays, Merck KGaA, Discoverx Corporation, Thermo Fisher Scientific Inc., Perkinelmer Inc., Promega Corporation, Proqinase GmbH, Enzo Life Sciences, Inc., Charles River Laboratories International, Inc., Biospherix, Ltd., Essen Bioscience, Marine Biological Laboratory, Miltenyi Biotec, Bioagilytix Labs., Lonza, Aurelia Bioscience Ltd., Selexis SA, Cell Biolabs, Inc., Biotek Instruments, Inc., Qgel SA.

Report ContentsRegional AnalysisReport Highlights

Market segments:
Market Drivers, Restraints and Opportunities
Market Size & Forecast 2016 to 2022
Supply & Demand Value Chain
Market – Current Trends
Competition & Major Companies
Technology and R&D Status
Porters Five Force Analysis
Strategic and Critical Success Factor Analysis of Key Players

North America
US and Canada

Latin America
Mexico, Brazil, Argentina and Rest of Latin America

Western Europe
EU5 (Germany, France, Italy, Spain, U.K.)
Nordic Countries (Denmark, Finland, Norway, and Sweden)
Benelux (Belgium, The Netherlands, and Luxembourg)
Rest of Western Europe

Eastern Europe
Russia
Poland
Rest of Eastern Europe

Asia Pacific
China
India
Japan
Australia and New Zealand
Rest of Asia Pacific

Middle East and Africa
GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
South Africa
North Africa
Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
Consumer and Pricing Analysis
Market dynamics of the industry

Market Segmentation
Estimated Market Sizing in terms of volume and value
Recent trends in Market and impact
Research Status and Technology Overview
Extensive Industry Structure Coverage

Read [email protected] https://www.kennethresearch.com/report-details/global-cell-based-assay-market/10064901

About Kenneth Research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us

Name: David

Email : [email protected]

Phone:+1 313 462 0609

RSS news